Research study on neutral thermodynamic atmospheric model

The Global Reference Atmospheric Model is used along with the revised perturbation statistics to evaluate and computer graph various atmospheric statistics along a space shuttle reference mission and abort trajectory. The trajectory plots are height vs. ground range, with height from ground level to 155 km and ground range along the reentry trajectory. Cross sectional plots, height vs. latitude or longitude, are also generated for 80 deg longitude, with heights from 30 km to 90 km and latitude from -90 deg to +90 deg, and for 45 deg latitude, with heights from 30 km to 90 km and longitudes from 180 deg E to 180 deg W. The variables plotted are monthly average pressure, density, temperature, wind components, and wind speed and standard deviations and 99th inter-percentile range for each of these variables

The NASA/MSFC global reference atmospheric model: MOD 3 (with spherical harmonic wind model)

Improvements to the global reference atmospheric model are described. The basic model includes monthly mean values of pressure, density, temperature, and geostrophic winds, as well as quasi-biennial and small and large scale random perturbations. A spherical harmonic wind model for the 25 to 90 km height range is included. Below 25 km and above 90 km, the GRAM program uses the geostrophic wind equations and pressure data to compute the mean wind. In the altitudes where the geostrophic wind relations are used, an interpolation scheme is employed for estimating winds at low latitudes where the geostrophic wind relations being to mesh down. Several sample wind profiles are given, as computed by the spherical harmonic model. User and programmer manuals are presented

Water-quality Effects on Phytoplankton Species and Density and Trophic State Indices at Big Base and Little Base Lakes, Little Rock Air Force Base, Arkansas, June through August, 2015

Big Base and Little Base Lakes are located on Little Rock Air Force Base, Arkansas, and their close proximity to a dense residential population and an active military/aircraft installation make the lakes vulnerable to water-quality degradation. The U.S. Geological Survey (USGS) conducted a study from June through August 2015 to investigate the effects of water quality on phytoplankton species and density and trophic state in Big Base and Little Base Lakes, with particular regard to nutrient concentrations. Nutrient concentrations, trophic-state indices, and the large part of the phytoplankton biovolume composed of cyanobacteria, indicate eutrophic conditions were prevalent for Big Base and Little Base Lakes, particularly in August 2015. Cyanobacteria densities and biovolumes measured in this study likely pose a low to moderate risk of adverse algal toxicity, and the high proportion of filamentous cyanobacteria in the lakes, in relation to other algal groups, is important from a fisheries standpoint because these algae are a poor food source for many aquatic taxa. In both lakes, total nitrogen to total phosphorus (N:P) ratios declined over the sampling period as total phosphorus concentrations increased relative to nitrogen concentrations. The N:P ratios in the August samples (20:1 and 15:1 in Big Base and Little Base Lakes, respectively) and other indications of eutrophic conditions are of concern and suggest that exposure of the two lakes to additional nutrients could cause unfavorable dissolved-oxygen conditions and increase the risk of cyanobacteria blooms and associated cyanotoxin issues

Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment-A Meta-Analysis and Systematic Review.

Early poor outcomes of intraocular inflammation (IOI) after intravitreal brolucizumab (IVB) have negatively affected the use of brolucizumab in clinical routine. We wished to identify factors related to the treatment details of IOI involving the posterior segment resulting from IVB for neovascular AMD (nAMD), if these were reported in detail. Articles were retrieved from PubMed, Scopus, ClinicalTrials, and CENTRAL using the following search terms: AND AND . The risk of bias was rated using the JBI Critical Appraisal Tool. We included 31 reports (41 patients and 46 eyes). Patients were 75.9 ± 8.5 years, and 58.5% were female. IOI occurred 41.7 ± 37.5 (median 37.0) days after treatment initiation with 2.0 ± 1.3 (1-6) IVB injections. A mean change in visual acuity of -14.6 ± 21.0 (median -6.5) letters was reported. The mean time from first IOI signs to the initiation of any anti-inflammatory treatment was 3.3 ± 6.2 days, with 63% of the patients receiving systemic corticosteroids as standard treatment. Finally, a period effect was observed, with a change in visual acuity of -25.3 ± 27.1 and -2.6 ± 7.3 letters in the chronologically first and last third, respectively, of treated eyes (effect size: r = 0.71; p = 0.006). Functional outcomes markedly improved with increasing experience in managing IOI

A Revised Thermosphere for the Mars Global Reference Atmospheric Model (Mars-GRAM Version 3.4)

This report describes the newly-revised model thermosphere for the Mars Global Reference Atmospheric Model (Mars-GRAM, Version 3.4). It also provides descriptions of other changes made to the program since publication of the programmer's guide for Mars-GRAM Version 3.34. The original Mars-GRAM model thermosphere was based on the global-mean model of Stewart. The revised thermosphere is based largely on parameterizations derived from output data from the three-dimensional Mars Thermospheric Global Circulation Model (MTGCM). The new thermospheric model includes revised dependence on the 10.7 cm solar flux for the global means of exospheric temperature, temperature of the base of the thermosphere, and scale height for the thermospheric temperature variations, as well as revised dependence on orbital position for global mean height of the base of the thermosphere. Other features of the new thermospheric model are: (1) realistic variations of temperature and density with latitude and time of day, (2) more realistic wind magnitudes, based on improved estimates of horizontal pressure gradients, and (3) allowance for user-input adjustments to the model values for mean exospheric temperature and for height and temperature at the base of the thermosphere. Other new features of Mars-GRAM 3.4 include: (1) allowance for user-input values of climatic adjustment factors for temperature profiles from the surface to 75 km, and (2) a revised method for computing the sub-solar longitude position in the 'ORBIT' subroutine

Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes.

An imbalance of plasma apolipoproteins has been linked to diabetic retinopathy (DR); however, there is scarce information regarding their presence in the aqueous humor (AH) and their role in DR. Here, we aimed at analysing the relationship between apolipoprotein concentrations in human AH and the severity of DR. Concentrations of apolipoproteins were measured retrospectively in patients with type 2 diabetes mellitus (T2DM) without DR (n = 23), with mild to moderate nonproliferative DR (NPDR) (n = 13), and advanced NPDR/proliferative DR (PDR) (n = 14) using a multiplex immunoassay. Compared to the non-apparent DR group, the concentrations of seven apolipoproteins were elevated in advanced NPDR/PDR (Apo AI 5.8-fold, Apo AII 4.5-fold, Apo CI 3.3-fold, Apo CIII 6.8-fold, Apo D 3.3-fold, Apo E 2.4-fold, and Apo H 6.6-fold). No significant differences were observed in apolipoprotein concentrations between patients with non-apparent DR and healthy controls (n = 17). In conclusion, the AH concentrations of apolipoproteins AI, AII, CI, CIII, D, E, and H increased in advancing stages of DR, suggesting their role in the pathogenesis of DR, which deserves further examination

Outer retinal features in OCT predict visual recovery after primary macula-involving retinal detachment repair.

PURPOSE To find predictive markers for the visual potential in optical coherence tomography (OCT) one month after surgical repair of macula-involving rhegmatogenous retinal detachment (miRD) with and without internal limiting membrane (ILM) peeling. METHODS This retrospective single-center, single-surgeon cohort study included 74 patients who underwent pars plana vitrectomy (PPV) for primary miRD between January 2013 and August 2020 with follow-up examinations for at least 6 months. Patients developing recurrent detachments, media opacities, or with an axial length over 27 mm were excluded from the analysis. LogMAR visual (VA) and LogRAD reading acuity (RA) ± standard deviation (SD), and OCT measurements 6 months after surgery were compared to OCT and VA measurements one month after surgery using multiple linear regression analysis for predictions. RESULTS VA increased from 0.34 ± 0.25 at one month to 0.22 ± 0.21 after 6 months [p < 0.001; effect size = -0.662, 95% confidence interval (CI): -(0.99-0.33)]. The continuity of the external limiting membrane (ELM) and ellipsoid zone (EZ) increased between 1 and 6 months. Subfoveal ELM integrity after one month predicted VA [adjusted R2 of 8.0%, F(2, 71) = 4.17, p = 0.018] and RA [adjusted R2 of 29%, F(2, 27) = 6.81, p = 0.002] after 6 months. EZ integrity had a less pronounced predictive effect on VA and RA. ELM integrity after 1 month correlated with better reading acuity after 6 months (p = 0.016). CONCLUSION VA and morphological OCT parameters improve between 1 and 6 months after surgery for miRD. The grade of ELM is a better predictor for RA than for VA, explaining more variance

Titrated oral misoprostol solution- a new method of labour induction

Background. Misoprostol, a cheap, stable, orally active prostaglandin analogue, is effective for labour induction when administered either vaginally or orally, but uterine hyperstimulation and rupture have been reported. Previous studies of oral misoprostol for labour induction have used fixed dosages 3 - 6-hourly.Objectives. To develop a new method of misoprostol use for labour induction using very small, frequent, titrated oral dosages, and to pilot effectiveness.Study design. Open clinical pilot study.Setting. Coronation Hospital, an academic hospital in Johannesburg, South Africa.Methods. We developed a method using 2-hourly titrated misoprostol doses commencing with 20 μg, increased after three doses to 40 μg. To administer such small doses we dissolved one rnisoprostol tablet in 200 ml water. A pilot study of this method was undertaken in 25 women with various indications for induction of labour.Results. Eighteen women (72%) delivered vaginally within 32 hours of induction and two women developed uterine hyperstirnulation. The caesarean section rate was 20%.Conclusions. Women may respond to much smaller dosages of misoprostol than are currently in use. A multicentre randomised trial of this method is underway. We emphasise the dangers inherent in the current unregistered use of misoprostol in clinical practice

Polymersome-based protein drug delivery – quo vadis?

Protein-based therapeutics are an attractive alternative to established therapeutic approaches and represent one of the fastest growing families of drugs. While many of these proteins can be delivered using established formulations, the intrinsic sensitivity of proteins to denaturation sometimes calls for a protective carrier to allow administration. Historically, lipid-based self-assembled structures, notably liposomes, have performed this function. After the discovery of polymersome-based targeted drug-delivery systems, which offer manifold advantages over lipid-based structures, the scientific community expected that such systems would take the therapeutic world by storm. However, no polymersome formulations have been commercialised. In this review article, we discuss key obstacles for the sluggish translation of polymersome-based protein nanocarriers into approved pharmaceuticals, which include limitations imparted by the use of non-degradable polymers, the intricacies of polymersome production methods, and the complexity of the in vivo journey of polymersomes across various biological barriers. Considering this complex subject from a polymer chemist's point of view, we highlight key areas that are worthy to explore in order to advance polymersomes to a level at which clinical trials become worthwhile and translation into pharmaceutical and nanomedical applications is realistic